Laparoscopic intracorporeal anastomosis is the future standard for ileostomy reversal in Crohn’s disease

In this editorial, we comment on an article by Liu <i>et al</i>. We focus specifically on the novel use of laparoscopic intracorporeal anastomosis (LIA) compared with open ileostomy reversal in patients with Crohn's disease (CD), which is an innovative approach for improving postoperative outcomes and accelerating recovery in ileostomy reversal procedures. This study also highlights the limitations of the conventional open surgical technique, which is associated with higher rates of feeding intolerance, prolonged hospital stays, and delayed initiation of enteral nutrition. The chronic and recurrent nature of CD and the challenges posed by traditional surgical methods are issues addressed by LIA, which offers a minimally invasive approach that reduces surgical trauma, shortens recovery time, and improves tolerance to enteral nutrition, thereby enhancing postoperative outcomes. However, while LIA shows great promise, further prospective multicenter trials are needed to validate these findings and assess their broader application in other surgical scenarios. Overall, LIA represents a significant advancement in minimally invasive surgery for CD and has the potential to become the preferred standard approach for ileostomy reversal in patients requiring bowel reanastomosis.